FTSJ1 Antibodies

Santa Cruz Biotechnology delivers a wide array of FTSJ1 monoclonal antibodies for research focused on understanding FTSJ1 protein function. FTSJ1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FTSJ1, or FTSJ homolog 1, is a crucial protein involved in the modification of ribosomal RNA, playing a significant role in ribosome biogenesis and protein synthesis. Its function is essential for cellular growth and proliferation, making it a key player in various biological processes. Dysregulation of FTSJ1 has been linked to several diseases, highlighting its importance as a potential biomarker and therapeutic target. FTSJ1 research continues to reveal new insights into cellular mechanisms and disease pathways. Understanding FTSJ1's role in RNA modification and protein synthesis opens new avenues for therapeutic development. Recent studies have demonstrated FTSJ1's involvement in multiple cellular pathways, emphasizing its biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FTSJ1's role in health and disease.